Approvals· July 28, 2026 · 23 min read
Lytenava & Wet AMD: First FDA-Approved Ophthalmic Bevacizumab and Buy-and-Bill
By Ran Chen#FDA Approval#Wet AMD#Anti-VEGF
Neovascular (wet) age-related macular degeneration therapies, anti-VEGF administration, vision outcomes, and Part B reimbursement.